artesunic acid has been researched along with Carcinoma, Epidermoid in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, X; Wang, W; Zhang, S | 1 |
| Li, M; Meng, J; Sun, JH | 1 |
| Hu, H; Ke, Y; Xiao, Q; Yang, L | 1 |
| Chen, Y; Du, Y; Liu, J; Liu, L; Wang, J; Wang, L | 1 |
| Efferth, T; Erich, SA; Fleckenstein, L; Grinwis, GC; London, CA; Mol, JA; Rutteman, GR; Spee, B | 1 |
| Chai, J; Chen, W; Cheng, Y; Chuang, HH; Jiang, Z; Li, S; Wang, T; Zhou, D | 1 |
6 other study(ies) available for artesunic acid and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Artesunate restrains the malignant progression of human cutaneous squamous cell carcinoma cells via the suppression of the PI3K/AKT pathway.
Topics: Apoptosis; Artesunate; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Insulin-Like Growth Factor I; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Skin Neoplasms | 2022 |
[Artesunate inhibited human tongue squamous cell carcinoma CAL27 cells in vitro via STAT3 signaling pathway].
Topics: Apoptosis; Artesunate; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Matrix Metalloproteinase 9; RNA, Messenger; Signal Transduction; STAT3 Transcription Factor; Tongue; Tongue Neoplasms; Vascular Endothelial Growth Factor A | 2022 |
Artesunate targets oral tongue squamous cell carcinoma via mitochondrial dysfunction-dependent oxidative damage and Akt/AMPK/mTOR inhibition.
Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Artesunate; Carcinoma, Squamous Cell; Humans; Mice; Mice, SCID; Mitochondria; Oxidative Stress; Proto-Oncogene Proteins c-akt; Tongue Neoplasms | 2020 |
Correlation between adenosine triphosphate (ATP)-binding cassette transporter G2 (ABCG2) and drug resistance of esophageal cancer and reversal of drug resistance by artesunate.
Topics: Adult; Aged; Animals; Antineoplastic Agents; Artemisinins; Artesunate; ATP Binding Cassette Transporter, Subfamily G, Member 2; Carcinoma, Squamous Cell; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Neoplasm Proteins; Xenograft Model Antitumor Assays | 2018 |
Safety and efficacy field study of artesunate for dogs with non-resectable tumours.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Carcinoma, Squamous Cell; Cell Proliferation; Dog Diseases; Dogs; Lymphoma; Mouth Neoplasms; Treatment Outcome; Tumor Cells, Cultured | 2013 |
Artesunate induces G0/G1 cell cycle arrest and iron-mediated mitochondrial apoptosis in A431 human epidermoid carcinoma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Artemisinins; Artesunate; Carcinoma, Squamous Cell; Caspase 3; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; G1 Phase Cell Cycle Checkpoints; Humans; Iron; Keratinocytes; Mitochondria; Resting Phase, Cell Cycle | 2012 |